Cooper Financial Group »

Alnylam Pharmaceuticals shares owned by Cooper Financial Group

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Cooper Financial Group from 13F filings

Historical chart of Cooper Financial Group investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Cooper Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Cooper Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $272k 597 456.00

More positions owned by Cooper Financial Group

Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Bd Index Fds Intermed Term (BIV)
Microsoft Corporation (MSFT)
Global X Fds Us Infr Dev Etf (PAVE)
Amazon (AMZN)
J P Morgan Exchange Traded F Equity Premium (JEPI)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Broadcom (AVGO)
Putnam Etf Trust Focused Lar Cap (PVAL)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Cooper Financial Group

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals